TopFunds

Agilent Technologies

NYSE: A

Stock price

154.78 USD

(+0%) TODAY

Life Sciences Tools & ServicesMedical - Diagnostics & Research

Financial Performance

Share

5Y price score: (15)

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 243.2%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    108.3

    52-week range

    160.5

    154.78

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    2.9 %

    Dividend Yield TTM

    0.7 %

    Market cap $

    $ 43,715

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    31.1

    Price / Book TTM

    6.2

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    0.5

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    30.7 %

    (8.1) %

    243.2 %

    Free cash flow per share growth

    247 %

    57.8 %

    11 %

    Earnings per share growth

    60 %

    98.7 %

    280.8 %

    Founded: 1,999

    Employees: 17,900

    Business Summary:Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    2026 Q2 (May 27, 2026)

    1) Strong Q2 Performance and Strategic Execution - Agilent reported Q2 2026 revenue of $1.83 billion, a 6.3% increase on a core basis, exceeding guidance. - Operating margin improved to 26.4%, a 130 basis point year-over-year increase, driven by operational efficiencies and the Ignite operating system. - Earnings per share (EPS) reached $1.49, reflecting a 14% growth year-over-year, also surpassing guidance. - Key strategic initiatives include enhanced customer intimacy, innovation-driven product launches, and operational discipline.

    2) Segment and Market Performance - Pharma grew 6%, with biotech showing low double-digit growth, supported by strong demand from large-cap companies. - Chemical and Advanced Materials (CAM) reported 8% growth, driven by semiconductor demand and capital expenditures in the Americas. - Diagnostics and Clinical saw an 11% increase, bolstered by expanding cancer diagnostics offerings. - Forensics achieved over 50% growth, aided by the TSA security contract and multiple large tender wins in Asia and Europe.

    3) Operational Improvements and Innovations - The Ignite operating system is yielding significant benefits, including strategic pricing that contributed 200 basis points to revenue growth. - Agilent is launching several innovative products at the upcoming ASMS conference, including the 9,500 triple quad ICPMS and upgraded GCs, aimed at enhancing customer workflows. - The company is also expanding its consumables portfolio, with strong traction in its Altura, Ultra, and Elite columns.

    4) Guidance and Outlook - Agilent raised its full-year guidance, expecting core growth of 4.5% to 6% and EPS of $6.00 to $6.10. - The company anticipates continued strength in key markets, although challenges remain in the academic and government sectors, particularly in China. - The outlook reflects confidence in operational execution, innovation, and the ability to absorb inflationary pressures.

    5) Challenges and Market Dynamics - The company noted a 9% decline in revenue from China, attributed to funding delays and a challenging macro environment. - Academic and government markets are expected to remain muted, with ongoing uncertainties around funding. - The impact of geopolitical tensions, particularly in the Middle East, is being monitored closely, but the company remains optimistic about long-term growth prospects.

    Bottom line: Agilent's strong Q2 results, driven by strategic execution and operational improvements, position the company well for sustained growth despite some market challenges. The raised guidance reflects confidence in continued performance across key segments, particularly in pharma and diagnostics, while navigating geopolitical and economic headwinds.

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Agilent Technologies — Financial Overview, Stock Price, Market Cap

    Agilent Technologies is a company. Founded in 1999. As of August 26, 2026, the company's market capitalization is $43714824960 with a current stock price of $154.78.